SAN CARLOS, Calif. — Last week SleepQuest announced a 44 percent increase in 2010 fourth quarter earnings over 2009, citing growth in all areas of the business including diagnostics, titration, therapy and ongoing care for OSA patients.
"2010 was an extraordinary year for SleepQuest as we continued our national expansion and expanded operations," Robert Koenigsberg, president and CEO, said in a release.
To keep its expansion going, the company has appointed Gary B. Corbett as vice-president of business strategy and development. "With over a decade focused on delivering medical services and products directly to patients in their home, he has a wealth of experience and new ideas to make health care more efficient and affordable," said Koenigsberg.
The company also announced that David L. Goldsmith and Donald G. Nelson have joined its independent board of directors. Goldsmith most recently served as chairman of the board for Apria during its $1.7 billion buyout by The Blackstone Group in 2008.
Said Goldsmith, "SleepQuest is a transformational company with an advanced technological infrastructure and collaborative clinical model that joins physicians, patients and payers in a comprehensive program of early diagnosis and prompt, effective therapy that reduces the cost of health care."
Nelson is an investment banker and venture capitalist who "has advised entrepreneurial and mid-sized companies in the completion of over $6 billion in mergers and acquisitions," according to the release.